| Literature DB >> 31100906 |
Guillermo Olcina1, Miguel Ángel Perez-Sousa2,3, Juan Antonio Escobar-Alvarez4, Rafael Timón5.
Abstract
Running performance is a determinant factor for victory in Sprint and Olympic distance triathlon. Previous cycling may impair running performance in triathlons, so brick training becomes an important part of training. Wearable technology that is used by triathletes can offer several metrics for optimising training in real-time. The aim of this study was to analyse the effect of previous cycling on subsequent running performance in a field test, while using kinematics metrics and SmO2 provided by wearable devices that are potentially used by triathletes. Ten trained triathletes participated in a randomised crossover study, performing two trial sessions that were separated by seven days: the isolated run trial (IRT) and the bike-run trial (BRT). Running kinematics, physiological outcomes, and perceptual parameters were assessed before and after each running test. The running distance was significantly lower in the BRT when compared to the IRT, with a decrease in stride length of 0.1 m (p = 0.00) and higher %SmO2 (p = 0.00) in spite of the maximal intensity of exercise. No effects were reported in vertical oscillation, ground contact time, running cadence, and average heart rate. These findings may only be relevant to 'moderate level' triathletes, but not to 'elite' ones. Triathletes might monitor their %SmO2 and stride length during brick training and then compare it with isolated running to evaluate performance changes. Using wearable technology (near-infrared spectroscopy, accelerometry) for specific brick training may be a good option for triathletes.Entities:
Keywords: NIRS; SmO2; monitoring; stride length; wearable
Year: 2019 PMID: 31100906 PMCID: PMC6572577 DOI: 10.3390/sports7050115
Source DB: PubMed Journal: Sports (Basel) ISSN: 2075-4663
Figure 1Testing protocol.
Kinematics, physiological, and perceptual measures from time trial.
| Variables | BRT |
|---|---|
| Relative power (w/kg) | 3.4 ± 0.4 |
| Cadence (revolutions per min) | 95.8 ± 7.4 |
| HR average (bpm) | 162 ± 12.8 |
| HR peak (bpm) | 175 ± 12.7 |
| RPE (units) | 16.5 ± 2.5 |
| VAS pain 0–10 (units) | 5.9 ± 2.1 |
BRT as mean ± SD.
Kinematics, physiological and perceptual measures changes from IRT to BRT.
| Variables | IRT | BRT | % (CL 90%) | ES (CL 90%) | |
|---|---|---|---|---|---|
| 12-min run (m) | 3345 ± 306 | 3150 ± 296 | −5.8 (−8.2 to −3.4) | 0.6 (0.3 to 0.8) | 0.00 |
| Cadence (step per min) | 178 ± 8.5 | 177 ± 8.8 | −0.3 (−2.6 to 2.0) | 0.0 (−0.3 to 0.4) | 0.81 |
| Vertical Oscillation (cm) | 9.5 ± 1.3 | 9.7 ± 1.3 | 2.1 (−1.9 to 6.3) | 0.1 (−0.4 to 0.1) | 0.34 |
| Ground contact time (ms) | 206± 16.6 | 209 ± 19.2 | 1.6 (−0.1 to 3.2) | 0.1 (0.0 0.3) | 0.12 |
| Stride Length (m) | 1.64 ± 0.11 | 1.52 ± 0.11 | −4.2 (−6.2 to −2.1) | 0.4 (0.1 to 0.5) | 0.00 |
| SmO2 average (%) | 41.5 ± 6.4 | 55.1 ± 3.3 | 35.7 (22.7 to 46.4) | 1.63 (1.16 to 2.26) | 0.00 |
| HR average (bpm) | 175 ± 11.0 | 173 ± 10.5 | −0.9 (−1.7 to 0.0) | 0.1 (0.0 to 0.2) | 0.09 |
| HR peak (bpm) | 184 ± 12.2 | 181 ± 11.3 | −1.7 (−2.6 to −0.9) | 0.2 (0.1 to 0.3) | 0.00 |
| RPE (units) | 17.4 ± 1.8 | 17.2 ± 1.7 | −1.1 (−9.3 to 7.9) | 0.0 (−0.6 to 0.8) | 0.80 |
| VAS pain 0–10 (units) | 5.4 ± 2.7 | 6.2 ± 2.1 | 22.6 (−1.8 to 53.1) | 0.3 (0.0 to 0.7) | 0.25 |
IRT–BRT as mean ± SD % (CL 90%) = percentage of change with 90% confidence limits. ES (CL 90%) = Effect size and 90% confidence limits.
Figure 2%SmO2 slope between Isolated Run Trial (IRT) and Bike-Run Trial (BRT). * p < 0.05 ** p < 0.01.